The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACER THERAPEUTICS INC | COM | 00444P108 | 3,370 | 109,270 | SH | SOLE | 109,270 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259103 | 262 | 267,500 | SH | SOLE | 267,500 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 800 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | |
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 1,155 | 71,000 | SH | SOLE | 71,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 7,963 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 14,857 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 3,834 | 200,000 | SH | Call | SOLE | 0 | 0 | 0 | |
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 5,066 | 71,500 | SH | SOLE | 71,500 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 34,540 | 930,000 | SH | SOLE | 930,000 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 5,478 | 147,500 | SH | Call | SOLE | 0 | 0 | 0 | |
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 4,975 | 132,500 | SH | SOLE | 132,500 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 2,020 | 53,800 | SH | Call | SOLE | 0 | 0 | 0 | |
CAS MED SYS INC | COM PAR | 124769209 | 12,001 | 5,263,508 | SH | SOLE | 5,263,508 | 0 | 0 | ||
CHEMBIO DIAGNOSTICS INC | COM NEW | 163572209 | 21,321 | 2,030,533 | SH | SOLE | 2,030,533 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 5,833 | 353,500 | SH | SOLE | 353,500 | 0 | 0 | ||
COHERUS BIOSCIENCES INC | COM | 19249H103 | 825 | 50,000 | SH | Call | SOLE | 0 | 0 | 0 | |
ENDOCYTE INC | COM | 29269A102 | 1,634 | 92,000 | SH | SOLE | 92,000 | 0 | 0 | ||
GTX INC DEL | COM NEW | 40052B207 | 157 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
IMMUNOMEDICS INC | COM | 452907108 | 42,816 | 2,055,500 | SH | SOLE | 2,055,500 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 25,005 | 2,222,701 | SH | SOLE | 2,222,701 | 0 | 0 | ||
IRIDEX CORP | COM | 462684101 | 12,367 | 1,947,500 | SH | SOLE | 1,947,500 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 24,699 | 7,395,000 | SH | SOLE | 7,395,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,849 | 128,844 | SH | SOLE | 128,844 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 7,066 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 2,042 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
ONCOBIOLOGICS INC | COM | 68235M105 | 29 | 29,082 | SH | SOLE | 29,082 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 8,081 | 20,000 | SH | Put | SOLE | 20,000 | 0 | 0 | |
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 9,587 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
VERACYTE INC | COM | 92337F107 | 10,433 | 1,092,500 | SH | SOLE | 1,092,500 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 2,916 | 311,500 | SH | SOLE | 311,500 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 6,369 | 482,500 | SH | SOLE | 482,500 | 0 | 0 |